Correlation Between Spyre Therapeutics and 456837AH6

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 456837AH6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 456837AH6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and ING GROEP N, you can compare the effects of market volatilities on Spyre Therapeutics and 456837AH6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 456837AH6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 456837AH6.

Diversification Opportunities for Spyre Therapeutics and 456837AH6

0.0

Correlation Coefficient

Spyre Therapeutics  456837AH6

Pay attention - limited upside

The 3 months correlation between Spyre and 456837AH6 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and ING GROEP N in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ING GROEP N and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 456837AH6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ING GROEP N has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 456837AH6 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 456837AH6

If you would invest  2,180  in Spyre Therapeutics on October 9, 2024 and sell it today you would earn a total of  255.00  from holding Spyre Therapeutics or generate 11.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.4%
Values	Daily Returns

Spyre Therapeutics  vs.  ING GROEP N

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

ING GROEP N

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ING GROEP N has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 456837AH6 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and 456837AH6

The main advantage of trading using opposite Spyre Therapeutics and 456837AH6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 456837AH6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 456837AH6 will offset losses from the drop in 456837AH6's long position.

The idea behind Spyre Therapeutics and ING GROEP N pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.